255 related articles for article (PubMed ID: 2106164)
1. Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.
Teicher BA; Holden SA; Eder JP; Herman TS; Antman KH; Frei E
Semin Oncol; 1990 Feb; 17(1 Suppl 3):18-32. PubMed ID: 2106164
[TBL] [Abstract][Full Text] [Related]
2. Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo.
Teicher BA; Holden SA; Cucchi CA; Cathcart KN; Korbut TT; Flatow JL; Frei E
Cancer Res; 1988 Jan; 48(1):94-100. PubMed ID: 3121169
[TBL] [Abstract][Full Text] [Related]
3. Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N,N',N''-triethylenethiophosphoramide.
Teicher BA; Waxman DJ; Holden SA; Wang YY; Clarke L; Alvarez Sotomayor E; Jones SM; Frei E
Cancer Res; 1989 Sep; 49(18):4996-5001. PubMed ID: 2504483
[TBL] [Abstract][Full Text] [Related]
4. Influence of scheduling on two-drug combinations of alkylating agents in vivo.
Teicher BA; Holden SA; Jones SM; Eder JP; Herman TS
Cancer Chemother Pharmacol; 1989; 25(3):161-6. PubMed ID: 2513139
[TBL] [Abstract][Full Text] [Related]
5. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
[TBL] [Abstract][Full Text] [Related]
6. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B
Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913
[TBL] [Abstract][Full Text] [Related]
8. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
9. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
10. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
[TBL] [Abstract][Full Text] [Related]
11. Interaction of N,N',N''-triethylenethiophosphoramide and N,N',N''-triethylenephosphoramide with cellular DNA.
Cohen NA; Egorin MJ; Snyder SW; Ashar B; Wietharn BE; Pan SS; Ross DD; Hilton J
Cancer Res; 1991 Aug; 51(16):4360-6. PubMed ID: 1714342
[TBL] [Abstract][Full Text] [Related]
12. Combination of etanidazole with cyclophosphamide and platinum complexes.
Teicher BA; Herman TS; Shulman L; Bubley G; Coleman CN; Frei E
Cancer Chemother Pharmacol; 1991; 28(3):153-8. PubMed ID: 1830248
[TBL] [Abstract][Full Text] [Related]
13. Interaction of interleukin-11 with cytotoxic therapies in vitro against CEM cells and in vivo against EMT-6 murine mammary carcinoma.
Teicher BA; Chen YN; Ara G; Emi Y; Kakeji Y; Maehara Y; Keyes S; Northey D
Int J Cancer; 1996 Sep; 67(6):864-70. PubMed ID: 8824560
[TBL] [Abstract][Full Text] [Related]
14. The proteasome inhibitor PS-341 in cancer therapy.
Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
16. Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP cells.
Ayash L; Korbut T; Herman TS; Teicher BA
Cancer Lett; 1991 Dec; 61(1):7-14. PubMed ID: 1764699
[TBL] [Abstract][Full Text] [Related]
17. Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.
Sotomayor EA; Teicher BA; Schwartz GN; Holden SA; Menon K; Herman TS; Frei E
Cancer Chemother Pharmacol; 1992; 30(5):377-84. PubMed ID: 1505076
[TBL] [Abstract][Full Text] [Related]
18. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
19. High-dose thiotepa alone and in combination regimens with bone marrow support.
Antman K; Eder JP; Elias A; Ayash L; Shea TC; Weissman L; Critchlow J; Schryber SM; Begg C; Teicher BA
Semin Oncol; 1990 Feb; 17(1 Suppl 3):33-8. PubMed ID: 2106166
[TBL] [Abstract][Full Text] [Related]
20. Modulation of thiotepa antitumor activity in vivo by alteration of liver cytochrome P450-catalyzed drug metabolism.
Chang TK; Chen G; Waxman DJ
J Pharmacol Exp Ther; 1995 Jul; 274(1):270-5. PubMed ID: 7616408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
